MedTrace Logo

Improving Antipsychotic Adherence Among Patients With Serious Mental Illness

NCT00057135 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2015-04-07

No results posted yet for this study

Summary

This is a randomized controlled trial examining the effectiveness of a pharmacy-based intervention designed to improve adherence with antipsychotic medications among patients with serious mental illness.

Conditions

Interventions

BEHAVIORAL

Unit of use medication packaging

BEHAVIORAL

Mailed reminders to patient when medication refills are due

BEHAVIORAL

Note to Mental Health Provider when refill is overdue

PROCEDURE

Aligning all prescriptions to fall due on same date

Sponsors & Collaborators

Principal Investigators

  • Marcia T. Valenstein, MD AB · VA Ann Arbor Healthcare System, Ann Arbor, MI

  • John Grabowski, MD · John D. Dingell VA Medical Center, Detroit, MI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-11-30
Completion
2006-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00057135 on ClinicalTrials.gov